ArticleOncology research2026

Clinical Value of the Systemic Immune Inflammation Index and PD-L1 Expression in Advanced NSCLC Treated with Pembrolizumab: Real-World Preliminary Study.

Hyungkeun Cha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.